共 50 条
ANCA-Associated Vasculitis
被引:1
|作者:
Sharma, Purva
[1
]
Zonozi, Reza
[2
,3
]
Geetha, Duvuru
[4
]
机构:
[1] Northwell Hlth, Glomerular Ctr, Div Kidney Dis & Hypertens, Great Neck, NY USA
[2] Nephrol Associates Northern Virginia, Fairfax, VA USA
[3] Inova Fairfax Hosp, Falls Church, VA USA
[4] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD USA
来源:
关键词:
ANCA;
Rituximab;
Plasmapheresis;
Vasculitis;
ANTIBODY-ASSOCIATED VASCULITIS;
RHEUMATOLOGY CLASSIFICATION CRITERIA;
2022;
AMERICAN-COLLEGE;
ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES;
DAILY ORAL CYCLOPHOSPHAMIDE;
RANDOMIZED-TRIAL;
PLASMA-EXCHANGE;
RENAL SURVIVAL;
CRESCENTIC GLOMERULONEPHRITIS;
WEGENERS-GRANULOMATOSIS;
D O I:
10.1053/j.akdh.2024.04.005
中图分类号:
R5 [内科学];
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号:
1002 ;
100201 ;
摘要:
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts. AAV tends to present in characteristic phenotypes categorized clinically as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic GPA (EGPA). Kidney involvement is a common feature of AAV, and has important implications on disease prognosis and management. Existing therapies have been refined and improvements in our understanding of the pathophysiology of AAV has led to approval of novel therapies. In this review, we provide an overview of epidemiology, disease mechanisms, clinical presentation and review therapeutic strategies for induction and maintenance of remission.
引用
收藏
页码:194 / 205
页数:12
相关论文